Korean J Physiol Pharmacol.  2018 May;22(3):225-234. 10.4196/kjpp.2018.22.3.225.

Mechanisms involved in adenosine pharmacological preconditioning-induced cardioprotection

• Singh L
• Kulshrestha R
• Singh N
• Jaggi AS

• KMID: 2410087
• DOI: http://doi.org/10.4196/kjpp.2018.22.3.225

Abstract

Adenosine is a naturally occurring breakdown product of adenosine triphosphate and plays an important role in different physiological and pathological conditions. Adenosine also serves as an important trigger in ischemic and remote preconditioning and its release may impart cardioprotection. Exogenous administration of adenosine in the form of adenosine preconditioning may also protect heart from ischemia-reperfusion injury. Endogenous release of adenosine during ischemic/remote preconditioning or exogenous adenosine during pharmacological preconditioning activates adenosine receptors to activate plethora of mechanisms, which either independently or in association with one another may confer cardioprotection during ischemia-reperfusion injury. These mechanisms include activation of K(ATP) channels, an increase in the levels of antioxidant enzymes, functional interaction with opioid receptors; increase in nitric oxide production; decrease in inflammation; activation of transient receptor potential vanilloid (TRPV) channels; activation of kinases such as protein kinase B (Akt), protein kinase C, tyrosine kinase, mitogen activated protein (MAP) kinases such as ERK 1/2, p38 MAP kinases and MAP kinase kinase (MEK 1) MMP. The present review discusses the role and mechanisms involved in adenosine preconditioning-induced cardioprotection.

Keyword

Adenosine; K(ATP) channels; Kinases; Preconditioning; TRPV

MeSH Terms

Adenosine Triphosphate
Adenosine*
Heart
Inflammation
Mitogen-Activated Protein Kinase Kinases
Nitric Oxide
Phosphotransferases
Protein Kinase C
Protein-Tyrosine Kinases
Proto-Oncogene Proteins c-akt
Receptors, Opioid
Receptors, Purinergic P1
Reperfusion Injury
Adenosine
Adenosine Triphosphate
Mitogen-Activated Protein Kinase Kinases
Nitric Oxide
Phosphotransferases
Protein Kinase C
Protein-Tyrosine Kinases
Proto-Oncogene Proteins c-akt
Receptors, Opioid
Receptors, Purinergic P1

Figure

• 

  Fig. 1 Possible mechanisms involved in adenosine preconditioning-induced cardioprotection.

Reference

1. Sheth S, Brito R, Mukherjea D, Rybak LP, Ramkumar V. Adenosine receptors: expression, function and regulation. Int J Mol Sci. 2014; 15:2024–2052. PMID: 24477263.

2. Mustafa SJ, Morrison RR, Teng B, Pelleg A. Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Handb Exp Pharmacol. 2009; 193:161–188.

3. Layland J, Carrick D, Lee M, Oldroyd K, Berry C. Adenosine: physiology, pharmacology, and clinical applications. JACC Cardiovasc Interv. 2014; 7:581–591. PMID: 24835328.

4. Liang BT, Jacobson KA. Adenosine and ischemic preconditioning. Curr Pharm Des. 1999; 5:1029–1041. PMID: 10607860.

5. Headrick JP, Ashton KJ, Rose'meyer RB, Peart JN. Cardiovascular adenosine receptors: expression, actions and interactions. Pharmacol Ther. 2013; 140:92–111. PMID: 23764371.

6. Ohta A, Sitkovsky M. The adenosinergic immunomodulatory drugs. Curr Opin Pharmacol. 2009; 9:501–506. PMID: 19539527.

7. Sachdeva S, Gupta M. Adenosine and its receptors as therapeutic targets: an overview. Saudi Pharm J. 2013; 21:245–253. PMID: 23960840.

8. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74:1124–1136. PMID: 3769170.

9. McCully JD, Toyoda Y, Uematsu M, Stewart RD, Levitsky S. Adenosine-enhanced ischemic preconditioning: adenosine receptor involvement during ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2001; 280:H591–H602. PMID: 11158956.

10. de Jong JW, de Jonge R, Keijzer E, Bradamante S. The role of adenosine in preconditioning. Pharmacol Ther. 2000; 87:141–149. PMID: 11007996.

11. Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage. Circulation. 1993; 87:208–215. PMID: 8419009.

12. Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension. 1991; 18:565–574. PMID: 1937658.

13. Schulz R, Rose J, Post H, Heusch G. Involvement of endogenous adenosine in ischaemic preconditioning in swine. Pflugers Arch. 1995; 430:273–282. PMID: 7675637.

14. Randhawa PK, Bali A, Jaggi AS. RIPC for multiorgan salvage in clinical settings: evolution of concept, evidences and mechanisms. Eur J Pharmacol. 2015; 746:317–332. PMID: 25176179.

15. Randhawa PK, Jaggi AS. Unraveling the role of adenosine in remote ischemic preconditioning-induced cardioprotection. Life Sci. 2016; 155:140–114. PMID: 27157518.

16. Singh A, Randhawa PK, Bali A, Singh N, Jaggi AS. Exploring the role of TRPV and CGRP in adenosine preconditioning and remote hind limb preconditioning-induced cardioprotection in rats. Cardiovasc Drugs Ther. 2017; 31:133–143. PMID: 28194544.

17. Baxter GF, Yellon DM. ATP-sensitive K+ channels mediate the delayed cardioprotective effect of adenosine A1 receptor activation. J Mol Cell Cardiol. 1999; 31:981–989. PMID: 10336838.

18. Tracey WR, Magee W, Masamune H, Oleynek JJ, Hill RJ. Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5′-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation. Cardiovasc Res. 1998; 40:138–145. PMID: 9876326.

19. Takano H, Bolli R, Black RG Jr, Kodani E, Tang XL, Yang Z, Bhattacharya S, Auchampach JA. A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res. 2001; 88:520–528. PMID: 11249876.

20. Dana A, Jonassen AK, Yamashita N, Yellon DM. Adenosine A(1) receptor activation induces delayed preconditioning in rats mediated by manganese superoxide dismutase. Circulation. 2000; 101:2841–2848. PMID: 10859291.

21. Hochhauser E, Kaminski O, Shalom H, Leshem D, Shneyvays V, Shainberg A, Vidne BA. Role of adenosine receptor activation in antioxidant enzyme regulation during ischemia-reperfusion in the isolated rat heart. Antioxid Redox Signal. 2004; 6:335–344. PMID: 15025935.

22. Surendra H, Diaz RJ, Harvey K, Tropak M, Callahan J, Hinek A, Hossain T, Redington A, Wilson GJ. Interaction of δ and κ opioid receptors with adenosine A1 receptors mediates cardioprotection by remote ischemic preconditioning. J Mol Cell Cardiol. 2013; 60:142–150. PMID: 23608604.

23. Kudo M, Wang Y, Xu M, Ayub A, Ashraf M. Adenosine A(1) receptor mediates late preconditioning via activation of PKC-delta signaling pathway. Am J Physiol Heart Circ Physiol. 2002; 283:H296–H301. PMID: 12063302.

24. Dana A, Skarli M, Papakrivopoulou J, Yellon DM. Adenosine A(1) receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism. Circ Res. 2000; 86:989–997. PMID: 10807872.

25. Germack R, Dickenson JM. Adenosine triggers preconditioning through MEK/ERK1/2 signalling pathway during hypoxia/ reoxygenation in neonatal rat cardiomyocytes. J Mol Cell Cardiol. 2005; 39:429–442. PMID: 16005018.

26. Zhao TC, Hines DS, Kukreja RC. Adenosine-induced late preconditioning in mouse hearts: role of p38 MAP kinase and mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol. 2001; 280:H1278–H1285. PMID: 11179074.

27. Ballard-Croft C, Kristo G, Yoshimura Y, Reid E, Keith BJ, Mentzer RM Jr, Lasley RD. Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete subcellular compartments. Am J Physiol Heart Circ Physiol. 2005; 288:H1359–H1366. PMID: 15539417.

28. Williams-Pritchard G, Knight M, Hoe LS, Headrick JP, Peart JN. Essential role of EGFR in cardioprotection and signaling responses to A1 adenosine receptors and ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2011; 300:H2161–H2168. PMID: 21460200.

29. Cohen MV, Baines CP, Downey JM. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol. 2000; 62:79–109. PMID: 10845085.

30. Li Y, Hu XX, Fu L, Chen J, Lu LH, Liu X, Xu Z, Zhou L, Wang ZP, Zhang X, Ou ZJ, Ou JS. Time window is important for adenosine preventing cold-induced injury to the endothelium. J Cardiovasc Pharmacol. 2017; 69:382–388. PMID: 28581447.

31. Wolff G, Truse R, Decking U. Extracellular adenosine formation by ecto-5′-nucleotidase (CD73) is no essential trigger for early phase ischemic preconditioning. PLoS One. 2015; 10:e0135086. PMID: 26261991.

32. Mastitskaya S, Marina N, Gourine A, Gilbey MP, Spyer KM, Teschemacher AG, Kasparov S, Trapp S, Ackland GL, Gourine AV. Cardioprotection evoked by remote ischaemic preconditioning is critically dependent on the activity of vagal pre-ganglionic neurones. Cardiovasc Res. 2012; 95:487–494. PMID: 22739118.

33. Jammes Y, Joulia F, Steinberg JG, Ravailhe S, Delpierre S, Condo J, Guieu R, Delliaux S. Endogenous adenosine release is involved in the control of heart rate in rats. Can J Physiol Pharmacol. 2015; 93:667–675. PMID: 26222197.

34. Pell TJ, Baxter GF, Yellon DM, Drew GM. Renal ischemia preconditions myocardium: role of adenosine receptors and ATP-sensitive potassium channels. Am J Physiol. 1998; 275:H1542–H1547. PMID: 9815059.

35. Liem DA, Verdouw PD, Ploeg H, Kazim S, Duncker DJ. Sites of action of adenosine in interorgan preconditioning of the heart. Am J Physiol Heart Circ Physiol. 2002; 283:H29–H37. PMID: 12063271.

36. Schulte G, Sommerschild H, Yang J, Tokuno S, Goiny M, Lövdahl C, Johansson B, Fredholm BB, Valen G. Adenosine A receptors are necessary for protection of the murine heart by remote, delayed adaptation to ischaemia. Acta Physiol Scand. 2004; 182:133–143. PMID: 15450109.

37. Leung CH, Wang L, Nielsen JM, Tropak MB, Fu YY, Kato H, Callahan J, Redington AN, Caldarone CA. Remote cardioprotection by transfer of coronary effluent from ischemic preconditioned rabbit heart preserves mitochondrial integrity and function via adenosine receptor activation. Cardiovasc Drugs Ther. 2014; 28:7–17. PMID: 24018748.

38. Tian Y, Piras BA, Kron IL, French BA, Yang Z. Adenosine 2B receptor activation reduces myocardial reperfusion injury by promoting anti-inflammatory macrophages differentiation via PI3K/Akt pathway. Oxid Med Cell Longev. 2015; 2015:585297. PMID: 26161239.

39. Montero MF, Saurim R, Bonservizi WG, Koike MK, Taha MO. Heart injury following intestinal ischemia reperfusion in rats is attenuated by association of ischemic preconditioning and adenosine. Acta Cir Bras. 2014; 29(Suppl 2):67–71. PMID: 25229518.

40. Shehata M. Cardioprotective effects of intracoronary adenosine in diabetic patients undergoing elective percutaneous coronary intervention. Minerva Cardioangiol. 2014; 62:461–471. PMID: 24699551.

41. Gopalakrishnan SM, Buckner SA, Milicic I, Groebe DR, Whiteaker KL, Burns DJ, Warrior U, Gopalakrishnan M. Functional characterization of adenosine receptors and coupling to ATP-sensitive K⁺ channels in Guinea pig urinary bladder smooth muscle. J Pharmacol Exp Ther. 2002; 300:910–917. PMID: 11861797.

42. Yang HQ, Foster MN, Jana K, Ho J, Rindler MJ, Coetzee WA. Plasticity of sarcolemmal KATP channel surface expression: relevance during ischemia and ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2016; 310:H1558–H1566. PMID: 27037371.

43. Husain K, Somani SM. Interaction of exercise and adenosine receptor agonist and antagonist on rat heart antioxidant defense system. Mol Cell Biochem. 2005; 270:209–214. PMID: 15792369.

44. Maggirwar SB, Dhanraj DN, Somani SM, Ramkumar V. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun. 1994; 201:508–515. PMID: 8002980.

45. Aggarwal S, Randhawa PK, Singh N, Jaggi AS. Preconditioning at a distance: Involvement of endothelial vasoactive substances in cardioprotection against ischemia-reperfusion injury. Life Sci. 2016; 151:250–258. PMID: 26979771.

46. Li Jm, Fenton RA, Wheeler HB, Powell CC, Peyton BD, Cutler BS, Dobson JG Jr. Adenosine A2a receptors increase arterial endothelial cell nitric oxide. J Surg Res. 1998; 80:357–364. PMID: 9878338.

47. Vials A, Burnstock G. A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide. Br J Pharmacol. 1993; 109:424–429. PMID: 8358543.

48. Shao Q, Casin KM, Mackowski N, Murphy E, Steenbergen C, Kohr MJ. Adenosine A1 receptor activation increases myocardial protein S-nitrosothiols and elicits protection from ischemia-reperfusion injury in male and female hearts. PLoS One. 2017; 12:e0177315. PMID: 28493997.

49. Sharma NK, Mahadevan N, Balakumar P. Adenosine transport blockade restores attenuated cardioprotective effects of adenosine preconditioning in the isolated diabetic rat heart: potential crosstalk with opioid receptors. Cardiovasc Toxicol. 2013; 13:22–32. PMID: 22948709.

50. Lee YC, Jung J, Park SJ. Remifentanil-induced preconditioning has cross-talk with A1 and A2B adenosine receptors in ischemicreperfused rat heart. Bosn J Basic Med Sci. 2016; 16:64–70. PMID: 26773185.

51. Yao L, Wong GT, Xia Z, Irwin MG. Interaction between spinal opioid and adenosine receptors in remote cardiac preconditioning: effect of intrathecal morphine. J Cardiothorac Vasc Anesth. 2011; 25:444–448. PMID: 20688538.

52. Mei B, Li W, Cheng X, Liu X, Gu E, Zhang Y. Activating mu-opioid receptors in the spinal cord mediates the cardioprotective effect of remote preconditioning of trauma. Cardiol J. 2017; 24:314–323. PMID: 27586455.

53. Avraamidou A, Marinis A, Asonitis S, Perrea D, Polymeneas G, Voros D, Argyra E. The impact of ischemic preconditioning on hemodynamic, biochemical and inflammatory alterations induced by intra-abdominal hypertension: an experimental study in a porcine model. Langenbecks Arch Surg. 2012; 397:1333–1341. PMID: 22760999.

54. Randhawa PK, Jaggi AS. TRPV1 and TRPV4 channels: potential therapeutic targets for ischemic conditioning-induced cardioprotection. Eur J Pharmacol. 2015; 746:180–185. PMID: 25449039.

55. Lei J, Zhu F, Zhang Y, Duan L, Lei H, Huang W. Transient receptor potential vanilloid subtype 1 inhibits inflammation and apoptosis via the release of calcitonin gene-related peptide in the heart after myocardial infarction. Cardiology. 2016; 134:436–443. PMID: 27144592.

56. Randhawa PK, Jaggi AS. Investigating the involvement of glycogen synthase kinase-3β and gap junction signaling in TRPV1 and remote hind preconditioning-induced cardioprotection. Eur J Pharmacol. 2017; 814:9–17. PMID: 28755986.

57. Randhawa PK, Jaggi AS. Investigating the involvement of TRPV1 ion channels in remote hind limb preconditioning-induced cardioprotection in rats. Naunyn Schmiedebergs Arch Pharmacol. 2017; 390:117–126. PMID: 27752734.

58. Naamani O, Chaimovitz C, Douvdevani A. Pharmacological preconditioning with adenosine A(1) receptor agonist suppresses cellular immune response by an A(2A) receptor dependent mechanism. Int Immunopharmacol. 2014; 20:205–212. PMID: 24560904.

59. Nakav S, Chaimovitz C, Sufaro Y, Lewis EC, Shaked G, Czeiger D, Zlotnik M, Douvdevani A. Anti-inflammatory preconditioning by agonists of adenosine A1 receptor. PLoS One. 2008; 3:e2107. PMID: 18461129.

60. Yang Z, Sun W, Hu K. Molecular mechanism underlying adenosine receptor-mediated mitochondrial targeting of protein kinase C. Biochim Biophys Acta. 2012; 1823:950–958. PMID: 22233927.

61. Lai CC, Tang CY, Chiang SC, Tseng KW, Huang CH. Ischemic preconditioning activates prosurvival kinases and reduces myocardial apoptosis. J Chin Med Assoc. 2015; 78:460–468. PMID: 26071976.

62. da Silva R, Grampp T, Pasch T, Schaub MC, Zaugg M. Differential activation of mitogen-activated protein kinases in ischemic and anesthetic preconditioning. Anesthesiology. 2004; 100:59–69. PMID: 14695725.

63. Xuan YT, Guo Y, Zhu Y, Wang OL, Rokosh G, Messing RO, Bolli R. Role of the protein kinase C-epsilon-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning. Circulation. 2005; 112:1971–1978. PMID: 16172266.

64. Yoshimura Y, Kristo G, Keith BJ, Jahania SA, Mentzer RM Jr, Lasley RD. The p38 MAPK inhibitor SB203580 blocks adenosine A(1) receptor-induced attenuation of in vivo myocardial stunning. Cardiovasc Drugs Ther. 2004; 18:433–440. PMID: 15770430.

65. Kis A, Baxter GF, Yellon DM. Limitation of myocardial reperfusion injury by AMP579, an adenosine A1/A2A receptor agonist: role of A2A receptor and Erk1/2. Cardiovasc Drugs Ther. 2003; 17:415–425. PMID: 15107596.

66. Yoshino T, Nagoshi T, Anzawa R, Kashiwagi Y, Ito K, Katoh D, Fujisaki M, Kayama Y, Date T, Hongo K, Yoshimura M. Preconditioning actions of aldosterone through p38 signaling modulation in isolated rat hearts. J Endocrinol. 2014; 222:289–299. PMID: 24895416.

67. Dou MY, Wu H, Zhu HJ, Jin SY, Zhang Y, He SF. Remifentanil preconditioning protects rat cardiomyocytes against hypoxia-reoxygenation injury via δ-opioid receptor mediated activation of PI3K/ Akt and ERK pathways. Eur J Pharmacol. 2016; 789:395–401. PMID: 27492364.